Cardiome Pharma Corp. (CRME) Jumps: Stock Rises 6.9% - Tale of the Tape

Cardiome Pharma Corp. (CRME) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock is now up 22.04% since Aug 1.

None of the estimates for this med-drugs industry stock were revised over the past seven days. The Zacks Consensus Estimate also remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cardiome Pharma holds a Zacks Rank #3 (Hold), while its Earnings ESP is negative.

Howerver, some better-ranked stocks in the same industry include Endo International plc (ENDP), Hyperion Therapeutics, Inc. (HPTX) and Portola Pharmaceuticals, Inc. (PTLA). All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

CARDIOME PHARMA (CRME): Free Stock Analysis Report

ENDO INTL PLC (ENDP): Free Stock Analysis Report

HYPERION THERAP (HPTX): Free Stock Analysis Report

PORTOLA PHARMA (PTLA): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs